AbbVie
ABBV
£139.73
Share price
3.15%
Change (1 day)
4.07%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
AbbVie (ABBV) - Total debt
Total debt on the balance sheet as of December 2024 : £50.42 Billion
According to AbbVie's latest financial reports the company's total debt is £50.42 Billion. A company’s total debt is the sum of all current and non-current debts.
AbbVie - Total debt on balance sheet (from 2011 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | £53.50 B | 14.79% |
| 2023-12-31 | £46.61 B | -10.87% |
| 2022-12-31 | £52.29 B | -7.94% |
| 2021-12-31 | £56.80 B | -10.02% |
| 2020-12-31 | £63.13 B | 24.07% |
| 2019-12-31 | £50.88 B | 60.24% |
| 2018-12-31 | £31.75 B | 14.85% |
| 2017-12-31 | £27.64 B | -7.4% |
| 2016-12-31 | £29.85 B | 39.71% |
| 2015-12-31 | £21.37 B | 122.16% |
| 2014-12-31 | £9.61 B | 7.78% |
| 2013-12-31 | £8.92 B | -7.95% |
| 2012-12-31 | £9.69 B | 31297.55% |
| 2011-12-31 | £30.88 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 | £47.79 B | -5.21% | 🇺🇸 USA |
 | £38.45 B | -23.75% | 🇺🇸 USA |
 | £25.26 B | -49.89% | 🇺🇸 USA |
 | £45.13 B | -10.49% | 🇺🇸 USA |
 | £20.05 B | -60.22% | 🇺🇸 USA |
 | £4.97 B | -90.13% | 🇺🇸 USA |
 | £16.00 B | -68.25% | 🇬🇧 UK |
 | £22.61 B | -55.15% | 🇬🇧 UK |
 | £0.34 B | -99.32% | 🇺🇸 USA |